Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis J V Galietta

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Biophysical Journal|December 17, 2009
The TMEM16 protein family: a new class of chloride channels?Luis J V Galietta
Current Opinion in Pharmacology|April 1, 2022
TMEM16A (ANO1) as a therapeutic target in cystic fibrosisLuis J V Galietta
Paediatric Drugs|June 13, 2013
Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctorsLuis J V Galietta
Physiological Reviews|April 3, 2014
Structure and function of TMEM16 proteins (anoctamins)Nicoletta Pedemonte, Luis J V Galietta
Frontiers in Pharmacology|October 13, 2012
Pharmacological Correctors of Mutant CFTR MistraffickingNicoletta Pedemonte, Luis J V Galietta
Cell Calcium|May 24, 2024
Anoctamin pharmacologyMichele Genovese, Luis J V Galietta
Current Opinion in Pharmacology|September 8, 2004
Identification of CFTR activators and inhibitors: chance or design?Luis J V Galietta, Oscar Moran
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2015
Targeting ion channels in cystic fibrosisMarcus A Mall, Luis J V Galietta
Nature Reviews. Drug Discovery|January 21, 2009
Chloride channels as drug targetsAlan S Verkman, Luis J V Galietta
American Journal of Physiology. Cell Physiology|October 13, 2021
Chloride transport modulators as drug candidatesAlan S Verkman, Luis J V Galietta
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Biophysical Journal|December 17, 2009
The TMEM16 protein family: a new class of chloride channels?Luis J V Galietta
Current Opinion in Pharmacology|April 1, 2022
TMEM16A (ANO1) as a therapeutic target in cystic fibrosisLuis J V Galietta
Paediatric Drugs|June 13, 2013
Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctorsLuis J V Galietta
Physiological Reviews|April 3, 2014
Structure and function of TMEM16 proteins (anoctamins)Nicoletta Pedemonte, Luis J V Galietta
Frontiers in Pharmacology|October 13, 2012
Pharmacological Correctors of Mutant CFTR MistraffickingNicoletta Pedemonte, Luis J V Galietta
Cell Calcium|May 24, 2024
Anoctamin pharmacologyMichele Genovese, Luis J V Galietta
Current Opinion in Pharmacology|September 8, 2004
Identification of CFTR activators and inhibitors: chance or design?Luis J V Galietta, Oscar Moran
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2015
Targeting ion channels in cystic fibrosisMarcus A Mall, Luis J V Galietta
Nature Reviews. Drug Discovery|January 21, 2009
Chloride channels as drug targetsAlan S Verkman, Luis J V Galietta
American Journal of Physiology. Cell Physiology|October 13, 2021
Chloride transport modulators as drug candidatesAlan S Verkman, Luis J V Galietta
Pageof 14